Hydralazine-Induced Pulmonary-Renal Syndrome: A Case Report

被引：5

作者：

Kalra, Ankur ^{[1
]}

Yokogawa, Naoto ^{[2
]}

Raja, Haroon ^{[1
]}

Palaniswamy, Chandrasekar ^{[3
]}

Desai, Priyank ^{[4
]}

Zanotti-Cavazzoni, Sergio L. ^{[4
]}

Rajaram, Sujanthy ^{[4
]}

机构：

[1] Cooper Univ Hosp, Dept Med, Camden, NJ 08103 USA

[2] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA

[3] New York Med Coll, Dept Med, Valhalla, NY 10595 USA

[4] Cooper Univ Hosp, Div Crit Care Med, Camden, NJ 08103 USA

来源：

AMERICAN JOURNAL OF THERAPEUTICS | 2012年 / 19卷 / 04期

关键词：

hydralazine vasculitis; hydralazine pulmonary-renal syndrome; drug-induced vasculitis; hydralazine pulmonary hemorrhage; hydralazine glomerulonephritis;

D O I：

10.1097/MJT.0b013e3181ed838c

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Drug-induced lupus erythematosus differs in its manifestation from drug-induced vasculitis. The former is associated with characteristic symptoms that improve following discontinuation, whereas the latter is predominantly an antineutrophil cytoplasmic antibody (ANCA) positive small vessel vasculitis involving the kidneys, skin, and lungs. We present a case of advanced disease in an elderly Caucasian woman requiring corticosteroids, and immunosuppressive therapy, who was on hydralazine for >2 years.

引用

页码：E136 / E138

页数：3